Comparative Analysis of Impulse Control Symptoms Among Individuals Receiving GPi-DBS or STN-DBS for Parkinson’s Disease
GPi-DBS may increase the risk for de novo ICDs. This observation should be interpreted with caution because of the small sample size and low statistical significance. Additional research may clarify the relationships between DBS targets and ICD outcomes.
Authors
- Hannah L. Combs (ORCID: https://orcid.org/0000-0001-6479-8662)
- A. Strutt
- Michele K. York (ORCID: https://orcid.org/0000-0003-4056-0742)
- Nicki Niemann
- Ashwin Viswanathan (ORCID: https://orcid.org/0000-0002-9602-8563)
- Hossein Heydari
- Joohi Jimenez-Shahed
- Megha S. Yadav
Institutions
- Barrow Neurological Institute (US)
- Mayo Clinic (US)
- Baylor College of Medicine (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of Neuropsychiatry
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1176/appi.neuropsych.20250111
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00